Jeffrey Glassberg
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Inhaled Mometasone to Promote Reduction in Vasoocclusive Events 2 (NCT03758950) | Jeffrey Glassberg | 2018-11-29 |
| Inhaled Mometasone to Reduce Painful Episodes in Patients With Sickle Cell Disease (NCT02061202) | Jeffrey Glassberg | 2014-03-01 |
Track Jeffrey Glassberg automatically
Every clearance here is in the API, with alerts when new ones post.